comparemela.com

Enovis (NYSE:ENOV – Free Report) had its price objective increased by Robert W. Baird from $67.00 to $70.00 in a report issued on Friday morning, Marketbeat.com reports. They currently have an outperform rating on the stock. A number of other research firms also recently issued reports on ENOV. Wells Fargo & Company upgraded shares of […]

Related Keywords

Phillip Benjamin Ben Berry ,Robertw Baird ,Needham Company ,Thrivent Financial For Lutherans ,Goldman Sachs Group Inc ,Enovis Corporation ,Equity Group ,Wells Fargo Company ,Free Report ,Stock Down ,Get Free Report ,Street Corp ,Sachs Group ,Enovis Daily ,Genovis ,Nyse Enov ,Senov ,Medical ,Boost Price Target ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.